Cargando…
A Machine Learning-Based Prediction Platform for P-Glycoprotein Modulators and Its Validation by Molecular Docking
P-glycoprotein (P-gp) is an important determinant of multidrug resistance (MDR) because its overexpression is associated with increased efflux of various established chemotherapy drugs in many clinically resistant and refractory tumors. This leads to insufficient therapeutic targeting of tumor popul...
Autores principales: | Kadioglu, Onat, Efferth, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829872/ https://www.ncbi.nlm.nih.gov/pubmed/31640190 http://dx.doi.org/10.3390/cells8101286 |
Ejemplares similares
-
Selection of safe artemisinin derivatives using a machine learning-based cardiotoxicity platform and in vitro and in vivo validation
por: Kadioglu, Onat, et al.
Publicado: (2021) -
Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking
por: Saeed, Mohamed, et al.
Publicado: (2015) -
Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning
por: Kadioglu, Onat, et al.
Publicado: (2021) -
In Silico and In Vitro Identification of P-Glycoprotein Inhibitors from a Library of 375 Phytochemicals
por: Schäfer, Julia, et al.
Publicado: (2023) -
Identification of Novel Anthracycline Resistance Genes and Their Inhibitors
por: Kadioglu, Onat, et al.
Publicado: (2021)